Clinical and Postdoctoral Research Fellowship Funding Competition from NMD4C, MDC, CSCN Now Open!
The NMD4C, in partnership with Muscular Dystrophy Canada (MDC) is now accepting applications for Post-doctoral Research Fellowships. The fellowship provides salary support for early-career scientists to conduct post-doctoral studies in a laboratory focused on research of NMDs. Successful applicants are eligible to receive up to $40,000 in funding over a one-year period.
In partnership with MDC and the Canadian Society for Clinical Neurophysiologists (CSCN), we are now also accepting applications for Clinical Fellowships. This national clinical fellowship in neuromuscular medicine and electromyography provides salary support of $80,000 for one year.
Both competitions close October 18, 2022. Click here for more information!
Competition Guidelines
Competition Dates
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.